medneo UK has over 20 mobile imaging vehicles offering MRI and CT scanning in operation across the UK. Image credit: medneo UK.

Mobile diagnostic imaging provider medneo UK has been acquired by private markets manager CVC for an undisclosed sum through its infrastructure strategy platform, CVC DIF.

Medneo UK, which specialises in providing magnetic resonance imaging (MRI) and computed tomography (CT) to UK National Health Service (NHS) trusts and healthcare providers, was established in 2018. Its parent company is Berlin-headquartered medneo Group, which was founded in 2011 and also has operations in Germany and Switzerland.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

With a fleet of more than 20 mobile scanning vehicles and a centre in West London, medneo UK provides MRI and CT imaging services to more than 130,000 patients per year.

According to a financial statement for the year ended 31 December 2023, medneo UK’s 2023 revenue climbed by over 18% in 2022 to almost £19m.

Under the acquisition, which CVC said will support the next phase of medneo UK’s growth, current medneo UK CEO Andy Spellman will stay on in his role.

“With CVC DIF’s support, we will be able to expand our services to serve even more patients whilst maintaining our focus on exemplary patient and customer care,” commented Spellman.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

CVC DIF was established last year after CVC acquired Amsterdam-headquartered DIF for an undisclosed sum.

CVC DIF partner and CIF investments head William Jansonius said CVC’s role in supporting medneo UK’s growth would include providing further investment to expand its fleet of scanners.

Other healthcare entities in CVC’s investment portfolio include New Jersey-headquartered pharmaceutical company Alvogen and France’s Cooper Consumer Health.

According to GlobalData, the UK’s diagnostic imaging market was valued at around $900m in 2023. Growing at a CAGR of 4.7%, it is projected to reach a valuation of almost $1.5bn by 2033.

Elsewhere in MRI, Siemens Healthineers recently installed the first MRI system of its kind in the UK at London’s Royal Brompton Hospital.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact